M&A Deal Summary |
|
|---|---|
| Date | 2025-06-23 |
| Target | SomaLogic |
| Sector | Life Science |
| Buyer(s) | Illumina |
| Sellers(s) | Standard BioTools |
| Deal Type | Divestiture |
| Deal Value | 350M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 10,590 |
| Revenue | 4.4B USD (2024) |
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. Illumina was formed in 1998 and is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 30 |
| Sector: Life Science M&A | 19 of 19 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Colorado M&A | 1 of 1 |
| Country: United States M&A | 21 of 21 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-09 |
Fluent BioSciences
Watertown, Massachusetts, United States Fluent BioSciences is a developer of an emerging and highly differentiated single-cell technology. Fluent BioSciences was formed in 2018 and is based in Watertown, Massachusetts. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Life Science |
| Employees | 814 |
| Revenue | 174M USD (2024) |
Standard BioTools is a biotechnology tools provider with a vision to improve life through comprehensive health insight. Fluidigm Corp. focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions and accelerate the development of more effective therapies. Standard BioTools was founded in 1999 and is based in South San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Colorado M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-05 |
SomaLogic
Boulder, Colorado, United States SomaLogic is a data-driven proteomics technology provides health-management information. SomaLogic was founded in 2000 and is based in Boulder, Colorado. |
Buy | - |
